MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
暂无分享,去创建一个
T. Ise | J. Wan | S. Khan | Mara C. Ebeling | M. Sikander | S. Behrman | Nadeem Zafar | M. Jaggi | S. Chauhan | B. Hafeez | P. Pradhan | Peeyush Sahay | S. Nagata | Aditya Ganju | Sonam Kumari | Hemendra Ghimire | M. Yallapu | M. Ebeling | Bilal B Hafeez
[1] M. Auer,et al. Proximity-dependent initiation of hybridization chain reaction , 2015, Nature Communications.
[2] J. Settleman. Predicting response to HER2 kinase inhibition , 2014, Oncotarget.
[3] P. Thompson,et al. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer , 2014, Oncotarget.
[4] M. Davidson,et al. The cancer glycocalyx mechanically primes integrin-mediated growth and survival , 2014, Nature.
[5] S. Batra,et al. Mucins in pancreatic cancer and its microenvironment , 2013, Nature Reviews Gastroenterology &Hepatology.
[6] S. Jain,et al. A Novel cyano derivative of 11‐Keto‐β‐Boswellic acid causes apoptotic death by disrupting PI3K/AKT/Hsp‐90 cascade, mitochondrial integrity, and other cell survival signaling events in HL‐60 cells , 2012, Molecular carcinogenesis.
[7] H. Aburatani,et al. MUC13 Mucin Augments Pancreatic Tumorigenesis , 2011, Molecular Cancer Therapeutics.
[8] A. Taflove,et al. Quantification of nanoscale density fluctuations by electron microscopy: probing cellular alterations in early carcinogenesis , 2011, Physical biology.
[9] M. Jaggi,et al. Mucin 13: Structure, Function, and Potential Roles in Cancer Pathogenesis , 2011, Molecular Cancer Research.
[10] Allen Taflove,et al. Quantification of nanoscale density fluctuations using electron microscopy: Light-localization properties of biological cells. , 2010, Applied physics letters.
[11] Vadim Backman,et al. Role of cytoskeleton in controlling the disorder strength of cellular nanoscale architecture. , 2010, Biophysical journal.
[12] S. Batra,et al. Mucin-interacting proteins: from function to therapeutics. , 2010, Trends in biochemical sciences.
[13] Deepak Kumar,et al. Mucins in ovarian cancer diagnosis and therapy , 2009, Journal of ovarian research.
[14] Ozlem Keskin,et al. Human Cancer Protein-Protein Interaction Network: A Structural Perspective , 2009, PLoS Comput. Biol..
[15] Vadim Backman,et al. Nanoscale cellular changes in field carcinogenesis detected by partial wave spectroscopy. , 2009, Cancer research.
[16] H. Aburatani,et al. Expression and functions of transmembrane mucin MUC13 in ovarian cancer. , 2009, Cancer research.
[17] Allen Taflove,et al. Optical methodology for detecting histologically unapparent nanoscale consequences of genetic alterations in biological cells , 2008, Proceedings of the National Academy of Sciences.
[18] J. Meza,et al. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. , 2008, Cancer research.
[19] P. Rao,et al. E-cadherin phosphorylation by protein kinase D1/protein kinase C{mu} is associated with altered cellular aggregation and motility in prostate cancer. , 2005, Cancer research.
[20] N. Hynes,et al. ErbB receptors: directing key signaling networks throughout life. , 2004, Annual review of pharmacology and toxicology.
[21] M. Schaller. Biochemical signals and biological responses elicited by the focal adhesion kinase. , 2001, Biochimica et biophysica acta.
[22] G. Sutherland,et al. MUC13, a Novel Human Cell Surface Mucin Expressed by Epithelial and Hemopoietic Cells* , 2001, The Journal of Biological Chemistry.
[23] M. Hollingsworth,et al. Identification of MUC1 proteolytic cleavage sites in vivo. , 2001, Biochemical and biophysical research communications.
[24] H. Ji,et al. C-erbB-2/ HER-2 upregulates fascin, an actin-bundling protein associated with cell motility, in human breast cancer cell lines , 2000, Oncogene.
[25] J. Mendelsohn,et al. Heregulin Regulates Cytoskeletal Reorganization and Cell Migration through the p21-activated Kinase-1 via Phosphatidylinositol-3 Kinase* , 1998, The Journal of Biological Chemistry.
[26] A. Harris,et al. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients. , 1998, Journal of clinical pathology.
[27] T. Hunter,et al. Focal Adhesion Kinase Overexpression Enhances Ras-dependent Integrin Signaling to ERK2/Mitogen-activated Protein Kinase through Interactions with and Activation of c-Src* , 1997, The Journal of Biological Chemistry.
[28] D. Lauffenburger,et al. Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.
[29] I. van Seuningen,et al. The membrane-bound mucins: how large O-glycoproteins play key roles in epithelial cancers and hold promise as biological tools for gene-based and immunotherapies. , 2008, Critical reviews in oncogenesis.